Status:
COMPLETED
Anderson Study 1 - Tart Cherry Study
Lead Sponsor:
Texas A&M University
Collaborating Sponsors:
Anderson Global Group, LLC
Conditions:
Health Services Research
Eligibility:
All Genders
30-60 years
Phase:
NA
Brief Summary
The purpose of this study is to examine if tart cherry reduces food-induced elevations in serum uric acid.
Detailed Description
Gout is a painful form of arthritis that is caused by hyperuricemia (high uric acid levels) that form crystals in the joints. Ingestion of food and/or beverages containing high purine levels (e.g., be...
Eligibility Criteria
Inclusion
- They are healthy males or females ages 30 to 60 years with fasting serum uric acid (UA) levels between 5.5 and 8.0 mg/dl obtained during the familiarization/screening visit;
- They have a willingness to provide voluntary, written, informed consent to participate in the study;
Exclusion
- They take prescription (Rx) medications (i.e., Uloric, Krystexxa, etc.) or dietary supplements known to have UA-reducing activity (i.e., black cherry, devil's claw, grape seed extracts, etc.);
- They have regular diseases requiring regular prescription (Rx) medications (birth control is allowed);
- They have abnormal/out of range values in laboratory tests determined at the familiarization/screening visit;
- They have an allergy to tart cherry or immunoglobulin E;
- They are pregnant, trying to become pregnant or breastfeeding;
Key Trial Info
Start Date :
April 10 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2021
Estimated Enrollment :
24 Patients enrolled
Trial Details
Trial ID
NCT04837274
Start Date
April 10 2020
End Date
June 1 2021
Last Update
June 27 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Exercise & Sport Nutrition Lab - Human Clinical Research Facility
College Station, Texas, United States, 77845